Press release

SEVN Investors Have the Opportunity to Join Investigation of Seven Hills Realty Trust with the Schall Law Firm

LOS ANGELES–(BUSINESS WIRE)–$SEVN—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

Read More »

KORE Investors Have the Opportunity to Join Investigation of KORE Group Holdings, Inc. with the Schall Law Firm

LOS ANGELES–(BUSINESS WIRE)–$KORE—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

Read More »

AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation With the Schall Law Firm

LOS ANGELES–(BUSINESS WIRE)–$AARD—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

Read More »

KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)

This is the first positive Phase 3 trial for WELIREG in earlier-stage disease, the first positive results for a HIF-2α…

Read More »

WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)

This is the first positive Phase 3 trial of a HIF-2 alpha inhibitor in combination with a multi-targeted tyrosine kinase…

Read More »

Berkshire Hathaway Inc. News Release

OMAHA, Neb.–(BUSINESS WIRE)–(BRK.A; BRK.B) – Berkshire’s operating results for the fourth quarter and full year of 2025 and 2024 are…

Read More »